Healthcare provider profile · identity verified

Pradeep K Singh, M.D.

Family Practice · LANCASTER, CA · NPI 1891737656

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	617	148
Lisinopril	Lisinopril	576	133
Omeprazole	Omeprazole	447	88
Levothyroxine Sodium	Levothyroxine Sodium	335	74
Amlodipine Besylate	Amlodipine Besylate	332	77
Metformin Hcl	Metformin Hcl	318	71
Montelukast Sodium	Montelukast Sodium	311	69
Atrovent Hfa	Ipratropium Bromide	301	74
Chlorthalidone	Chlorthalidone	301	66
Clopidogrel	Clopidogrel Bisulfate	247	58
Duloxetine Hcl	Duloxetine Hcl	222	45
Glipizide	Glipizide	221	53
Atenolol	Atenolol	202	43
Mirtazapine	Mirtazapine	194	46
Clonidine Hcl	Clonidine Hcl	190	37
Naproxen	Naproxen	187	37
Fenofibrate	Fenofibrate Nanocrystallized	174	40
Jardiance	Empagliflozin	165	32
Pravastatin Sodium	Pravastatin Sodium	157	44
Metoprolol Tartrate	Metoprolol Tartrate	148	38
Allopurinol	Allopurinol	136	32
Terazosin Hcl	Terazosin Hcl	129	32
Azithromycin	Azithromycin	127	90
Potassium Chloride	Potassium Chloride	127	32
Trazodone Hcl	Trazodone Hcl	123	28
Levetiracetam	Levetiracetam	122	19
Farxiga	Dapagliflozin Propanediol	120	27
Isosorbide Dinitrate	Isosorbide Dinitrate	120	24
Tizanidine Hcl	Tizanidine Hcl	99	21
Diclofenac Sodium	Diclofenac Sodium	98	32
Losartan Potassium	Losartan Potassium	97	26
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	96	35
Pantoprazole Sodium	Pantoprazole Sodium	96	24
Cefuroxime	Cefuroxime Axetil	95	57
Furosemide	Furosemide	94	30
Hydralazine Hcl	Hydralazine Hcl	94	20
Promethazine Hcl	Promethazine Hcl	93	33
Tamsulosin Hcl	Tamsulosin Hcl	91	25
Risperidone	Risperidone	90	13
Buspirone Hcl	Buspirone Hcl	89	23
Donepezil Hcl	Donepezil Hcl	87	20
Eliquis	Apixaban	86	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	84	20
Hydroxyzine Hcl	Hydroxyzine Hcl	83	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	17
Methylprednisolone	Methylprednisolone	81	58
Spiriva Respimat	Tiotropium Bromide	80	18
Memantine Hcl	Memantine Hcl	75	19
Warfarin Sodium	Warfarin Sodium	73	suppressed
Carvedilol	Carvedilol	70	21
Ozempic	Semaglutide	69	18
Mupirocin	Mupirocin	68	41
Sertraline Hcl	Sertraline Hcl	66	11
Simvastatin	Simvastatin	64	16
Roflumilast	Roflumilast	62	12
Rosuvastatin Calcium	Rosuvastatin Calcium	57	13
Famotidine	Famotidine	55	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	53	16
Fluticasone Propionate	Fluticasone Propionate	52	20
Meloxicam	Meloxicam	51	11
Tradjenta	Linagliptin	50	suppressed
Januvia	Sitagliptin Phosphate	49	suppressed
Valsartan	Valsartan	48	suppressed
Baclofen	Baclofen	46	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	46	14
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Nifedipine Er	Nifedipine	45	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	45	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	13
Dutasteride	Dutasteride	44	suppressed
Sucralfate	Sucralfate	44	14
Cetirizine Hcl	Cetirizine Hcl	43	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	17
Amoxicillin	Amoxicillin	40	23
Calcitonin-Salmon	Calcitonin,salmon,synthetic	40	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Ciclopirox	Ciclopirox Olamine	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	12
Diltiazem Hcl	Diltiazem Hcl	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	suppressed
Lactulose	Lactulose	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Colchicine	Colchicine	32	suppressed
Benztropine Mesylate	Benztropine Mesylate	31	suppressed
Leflunomide	Leflunomide	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	18
Gabapentin	Gabapentin	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	20
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Prednisone	Prednisone	27	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	25	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Fenofibrate	Fenofibrate,micronized	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Metoprolol Succinate	Metoprolol Succinate	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Bicalutamide	Bicalutamide	22	suppressed
Digoxin	Digoxin	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	21	12
Glyxambi	Empagliflozin/Linagliptin	21	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Misoprostol	Misoprostol	21	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	21	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Albuterol Sulfate	Albuterol Sulfate	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Dapagliflozin	Dapagliflozin Propanediol	19	14
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	17	suppressed
Finasteride	Finasteride	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Klor-Con 8	Potassium Chloride	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error